ArticleBMC cancer2024

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Elif Şenocak Taşçı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.